相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
Raul Alba et al.
BLOOD (2010)
Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates
Antonio Fontanellas et al.
MOLECULAR THERAPY (2010)
Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
Angela C. Bradshaw et al.
PLOS PATHOGENS (2010)
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba et al.
BLOOD (2009)
The Cell Adhesion Molecule CAR'' and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution
Elena Seiradake et al.
PLOS PATHOGENS (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer
E. Wisse et al.
GENE THERAPY (2008)
Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates
Fuminori Sakurai et al.
MOLECULAR THERAPY (2008)
Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver
Frederic Vigant et al.
MOLECULAR THERAPY (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy
Nicola Brunetti-Pierri et al.
MOLECULAR THERAPY (2007)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, αv integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity
N Koizumi et al.
HUMAN GENE THERAPY (2006)
The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors
J Schuettrumpf et al.
MOLECULAR THERAPY (2006)
Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2005)
Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons
SH Ni et al.
HUMAN GENE THERAPY (2005)
The influence of adenovirus fiber structure and function on vector development for gene therapy
SA Nicklin et al.
MOLECULAR THERAPY (2005)
Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats
CG Nicol et al.
MOLECULAR THERAPY (2004)
The size of sinusoidal fenestrae is a critical determinant of hepatocyte transduction after adenoviral gene transfer
J Lievens et al.
GENE THERAPY (2004)
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer
O Hamid et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates
TAG Smith et al.
HUMAN GENE THERAPY (2003)
CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice
H Mizuguchi et al.
GENE THERAPY (2002)
Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons
N Morral et al.
HUMAN GENE THERAPY (2002)
Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors
MA Schnell et al.
MOLECULAR THERAPY (2001)
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver
NJ Tao et al.
MOLECULAR THERAPY (2001)
分享论文
